Close
  Indian J Med Microbiol
 

Figure 4: Linear trend of inflammatory biomarkers across the different group of study participants. Mean expression of leukotriene A4 hydrolase (LTA4H) (A), leukotriene C4 synthase (LTC4S) (B), interleukin-8 (IL8) (C), Jun proto-oncogene (JUN) (D), prostaglandin-endoperoxide synthase 2 (PTGS2) (E), vascular endothelial growth factor A (VEGFA) (F) and interferon gamma (IFNG) (G) across four groups i.e. controls, without metabolic syndrome (MetS−), with MetS (MetS+) and coronary artery disease (CAD).

Figure 4: Linear trend of inflammatory biomarkers across the different group of study participants. Mean expression of leukotriene A4 hydrolase (<i>LTA4H</i>) (<b>A</b>), leukotriene C4 synthase (<i>LTC4S</i>) (<b>B</b>), interleukin-8 (<i>IL8</i>) (<b>C</b>), Jun proto-oncogene (<i>JUN</i>) (<b>D</b>), prostaglandin-endoperoxide synthase 2 (<i>PTGS2</i>) (<b>E</b>), vascular endothelial growth factor A (<i>VEGFA</i>) (<b>F</b>) and interferon gamma (<i>IFNG</i>) (<b>G</b>) across four groups <i>i.e</i>. controls, without metabolic syndrome (MetS−), with MetS (MetS+) and coronary artery disease (CAD).